$RNG
RingCentral, Inc.

2017 Q2 Form 10-Q Financial Statement

#000156459017016049 Filed on August 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4
Revenue $119.4M $104.5M
YoY Change 30.04% 25.24%
Cost Of Revenue $29.56M $24.70M
YoY Change 32.18% 7.86%
Gross Profit $90.36M $79.85M
YoY Change 30.05% 31.82%
Gross Profit Margin 75.65% 76.41%
Selling, General & Admin $74.37M $69.00M
YoY Change 25.83% 34.5%
% of Gross Profit 82.3% 86.41%
Research & Development $18.62M $17.40M
YoY Change 11.48% 13.73%
% of Gross Profit 20.6% 21.79%
Depreciation & Amortization $3.800M $3.910M
YoY Change 6.44% 10.76%
% of Gross Profit 4.21% 4.9%
Operating Expenses $92.99M $86.40M
YoY Change 22.83% 29.92%
Operating Profit -$2.627M -$6.606M
YoY Change -58.33% 10.17%
Interest Expense $9.000K -$200.0K
YoY Change -104.5% 0.0%
% of Operating Profit
Other Income/Expense, Net $569.0K -$100.0K
YoY Change -147.42% -85.71%
Pretax Income -$2.058M -$6.900M
YoY Change -73.32% 0.0%
Income Tax $57.00K $100.0K
% Of Pretax Income
Net Earnings -$2.115M -$6.946M
YoY Change -72.78% 0.07%
Net Earnings / Revenue -1.77% -6.65%
Basic Earnings Per Share
Diluted Earnings Per Share -$27.67K -$93.24K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.0M $160.4M
YoY Change 12.99% 16.58%
Cash & Equivalents $167.0M $160.4M
Short-Term Investments
Other Short-Term Assets $5.258M $5.470M
YoY Change -63.99% -54.42%
Inventory $124.0K $63.00K
Prepaid Expenses $12.55M $9.780M
Receivables $33.30M $30.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $218.2M $205.9M
YoY Change 16.88% 20.42%
LONG-TERM ASSETS
Property, Plant & Equipment $36.61M $31.99M
YoY Change 25.82% 13.45%
Goodwill $9.393M $9.393M
YoY Change 0.0% 0.0%
Intangibles $1.763M $2.244M
YoY Change -36.01% -31.29%
Long-Term Investments
YoY Change
Other Assets $2.600M $3.087M
YoY Change -18.75% 4.72%
Total Long-Term Assets $50.39M $46.72M
YoY Change 13.22% 6.63%
TOTAL ASSETS
Total Short-Term Assets $218.2M $205.9M
Total Long-Term Assets $50.39M $46.72M
Total Assets $268.6M $252.6M
YoY Change 16.18% 17.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.600M $7.810M
YoY Change 180.0% 50.31%
Accrued Expenses $49.70M $48.32M
YoY Change 11.19% 39.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $14.53M
YoY Change -100.0% 287.41%
Total Short-Term Liabilities $108.6M $116.0M
YoY Change 17.03% 43.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $312.0K
YoY Change -100.0% -97.9%
Other Long-Term Liabilities $3.175M $3.199M
YoY Change -57.67% -40.93%
Total Long-Term Liabilities $3.175M $3.511M
YoY Change -84.51% -82.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $108.6M $116.0M
Total Long-Term Liabilities $3.175M $3.511M
Total Liabilities $114.9M $122.6M
YoY Change 1.41% 17.11%
SHAREHOLDERS EQUITY
Retained Earnings -$253.8M -$239.5M
YoY Change 13.94%
Common Stock $404.8M $366.8M
YoY Change 14.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $153.7M $164.2M
YoY Change
Total Liabilities & Shareholders Equity $268.6M $252.6M
YoY Change 16.18% 17.6%

Cashflow Statement

Concept 2017 Q2 2016 Q4
OPERATING ACTIVITIES
Net Income -$2.115M -$6.946M
YoY Change -72.78% 0.07%
Depreciation, Depletion And Amortization $3.800M $3.910M
YoY Change 6.44% 10.76%
Cash From Operating Activities $8.740M $7.270M
YoY Change -11.45% 152.43%
INVESTING ACTIVITIES
Capital Expenditures -$5.500M -$5.250M
YoY Change 20.61% 25.0%
Acquisitions
YoY Change
Other Investing Activities $530.0K $0.00
YoY Change -100.0%
Cash From Investing Activities -$4.970M -$5.250M
YoY Change 8.99% 179.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.87M 5.770M
YoY Change 312.8% -10.12%
NET CHANGE
Cash From Operating Activities 8.740M 7.270M
Cash From Investing Activities -4.970M -5.250M
Cash From Financing Activities 13.87M 5.770M
Net Change In Cash 17.64M 7.790M
YoY Change 103.46% 4.99%
FREE CASH FLOW
Cash From Operating Activities $8.740M $7.270M
Capital Expenditures -$5.500M -$5.250M
Free Cash Flow $14.24M $12.52M
YoY Change -1.32% 76.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 rng Long Term Sales Tax Contingent Liability
LongTermSalesTaxContingentLiability
3077000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17936000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15313000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
218215000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
205911000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36613000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31994000
CY2017Q2 us-gaap Goodwill
Goodwill
9393000
CY2016Q4 us-gaap Goodwill
Goodwill
9393000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1763000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2244000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
366800000
CY2017Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
110413000
CY2016Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
86067000
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
5777000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
214100000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
166045000
CY2017Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
9023000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
130041000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
268617000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3175000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2737000
CY2016Q4 us-gaap Liabilities
Liabilities
122588000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239503000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
8000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
153722000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
404742000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3199000
CY2017Q2 us-gaap Liabilities
Liabilities
114895000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2815000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253843000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
252629000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
17127000
us-gaap Repayments Of Debt
RepaymentsOfDebt
14840000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
181000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1310000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-330000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6660000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137588000
us-gaap Interest Paid
InterestPaid
116000
us-gaap Income Taxes Paid
IncomeTaxesPaid
188000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
3000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Cer<font style="color:#000000;">tain immaterial items previously reported have been reclassified to conform to the current year&#8217;s reporting presentation.</font></p></div>
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The significant estimates made by management affect revenues, the allowance for doubtful accounts, goodwill, share-based compensation, capitalization of internally developed software, return reserves, provision for income taxes, uncertain tax positions, loss contingencies, sales tax liabilities, and accrued liabilities. Management periodically evaluates these estimates and will make adjustments prospectively based upon the results of such periodic evaluations. Actual results could differ from these estimates.</p></div>
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6100000
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6100000
CY2017Q2 us-gaap Cash
Cash
57237000
CY2017Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
109778000
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
29625000
CY2017Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
4159000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
520000
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12554000
CY2017Q2 us-gaap Inventory Net
InventoryNet
124000
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5258000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90107000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
53494000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14724000
CY2017Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
7897000
CY2017Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4994000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22105000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3850000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2087000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3850000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1606000
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
74065000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.94
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.08
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17815000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2932000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.431
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.479
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
301000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
602000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
602000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
258000
CY2016Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
14900000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
14800000
CY2017Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7000000
CY2016Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6000000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10627000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7477000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19562000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7384000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1202000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
326000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5881000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5738000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4768000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.59
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.99
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.44
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.16
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.17
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.00
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
155271000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
152311000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
132495000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
rng Percentage Of Billings Collected Through Credit Cards Of Geographical Revenue
PercentageOfBillingsCollectedThroughCreditCardsOfGeographicalRevenue
0.74
CY2017Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11312000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11286000

Files In Submission

Name View Source Status
0001564590-17-016049-index-headers.html Edgar Link pending
0001564590-17-016049-index.html Edgar Link pending
0001564590-17-016049.txt Edgar Link pending
0001564590-17-016049-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201708072036014472068.jpg Edgar Link pending
g201708072036043601777.jpg Edgar Link pending
g201708072036044211778.jpg Edgar Link pending
g201708072036053131779.jpg Edgar Link pending
g201708072036060631780.jpg Edgar Link pending
g201708072036065741781.jpg Edgar Link pending
g201708072036070681782.jpg Edgar Link pending
g201708072036071791783.jpg Edgar Link pending
g201708072036071871784.jpg Edgar Link pending
g201708072036071961785.jpg Edgar Link pending
g201708072036077101786.jpg Edgar Link pending
g201708072036077171787.jpg Edgar Link pending
g201708072036078041788.jpg Edgar Link pending
g201708072036078091789.jpg Edgar Link pending
g201708072036078121790.jpg Edgar Link pending
g201708072036078151791.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rng-10q_20170630.htm Edgar Link pending
rng-20170630.xml Edgar Link completed
rng-20170630.xsd Edgar Link pending
rng-20170630_cal.xml Edgar Link unprocessable
rng-20170630_def.xml Edgar Link unprocessable
rng-20170630_lab.xml Edgar Link unprocessable
rng-20170630_pre.xml Edgar Link unprocessable
rng-ex101_82.htm Edgar Link pending
rng-ex102_250.htm Edgar Link pending
rng-ex103_249.htm Edgar Link pending
rng-ex311_9.htm Edgar Link pending
rng-ex312_7.htm Edgar Link pending
rng-ex321_6.htm Edgar Link pending
rng-ex322_8.htm Edgar Link pending
Show.js Edgar Link pending